Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2009-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3669274bbf2c40baf585ff27ac76aa74 |
publicationDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7745138-B2 |
titleOfInvention |
Methods for determining drug responsiveness |
abstract |
The invention provides a diagnostics assay for measuring the responsiveness to a drug by comparing the mRNA levels of a gene that responds to the drug, such as a steroid, to the mRNA levels of a gene that does not respond to the drug. Methods according to the invention are useful for predicting the ability of a patient (or a tissue, body fluid or cell sample in vitro) to respond to a drug or steroid at any stage of their treatment (i.e., before, during or after), and to monitor the patient (or a tissue, body fluid or cell) over time to assess continued responsiveness to the drug or steroid. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8507430-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084426-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291212-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008193425-A1 |
priorityDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |